In episode 451, Mike and James invite Adrienne to talk about how we put all the osteoarthritis evidence into a simplified decision guide. We talk about how we produce these decision guides and also give tips and suggestions around how to use the evidence with patients.
Show notes
PEER simplified decision aid: osteoarthritis treatment options in primary care.
In episode 450 Mike and James continue, with Danielle and Joey, going over our osteoarthritis systematic review. We talk in detail about all the evidence around oral NSAIDs, glucosamine, topical NSAIDs, chondroitin, viscosupplementation, oral opioids, acetaminophen. And now you know all the numbers.
Show notes
PEER Umbrella Systematic Review of Systematic Reviews: Management of Osteoarthritis in Primary Care
In episode 449, Mike and James invite Danielle Perry and Joey Ton to go over our osteoarthritis systematic review. We talk about all the evidence around exercise, steroid injections, SNRIs, oral NSAIDs, glucosamine, topical NSAIDs, chondroitin, viscosupplementation, oral opioids, acetaminophen. In fact, the magnitude of benefit is exactly in this order – exercise highest, acetaminophen lowest.
Show notes
PEER Umbrella Systematic Review of Systematic Reviews: Management of Osteoarthritis in Primary Care
In episode 448, Mike and James go over all the evidence around masks for preventing viral respiratory infections in healthcare workers. We find that surgical masks and N95 masks provide similar protection against viral infections. Unfortunately we have no evidence for COVID-19.
Show notes
Tools for Practice
Unmasking the evidence around masks for healthcare workers
COVID Webinar
May 7
The COVID-19 Pivot: Rapid evidence reviews with the PEER team
In episode 447, Mike and James invite Tina and Mike to talk about a really important topic – is there asymptomatic transmission of COVID-19? The simple answer is yes. Have a listen and hear about all the data and the numbers.
Show notes
Tools for Practice
In episode 446, Mike and James invite Mike and Tina to talk about all things COVID. In this podcast we look at what are the presenting symptoms, the clinical course and the risk factors for mortality.
Show notes
Tools for Practice
In episode 445, Mike and James wade into the evidence-free zone (pretty much) around assessing dyspnea over a telephone/video conference. We talk about the Roth score, respiratory rate, fever, and patient self-rating of dyspnea. Have a listen and see what we found.
Show notes
The BMJ
In episode 444, James and Mike wade into the evidence quagmire around hydroxychloroquine and COVID-19. The bottom line is the evidence will likely be different around the time you listen to the podcast. So listen quickly.
Show notes
1)Tools for Practice
Hydroxychloroquine with or without azithromycin for COVID-19
2) Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
In episode 443, James and Mike continue with Mike Kolber and we discuss the evidence around electronic cigarettes and their use for smoking cessation. Overall, the podcast ends up being smoking hot in so many ways.
Show notes
Tools for Practice
Electronic Cigarettes – Hoot that helps, hurts, or just hype?
In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer.
Show notes
Tools for Practice
It’s all in the details… or is it? Biosimilars versus biologics for inflammatory conditions
THE NUTRITION PROPOSITION BOOK
Check it out at nutritionproposition.com and think about picking up a copy on Amazon. All the evidence you ever wanted about nutrition and the only nutrition book that won’t tell you what to eat.
